At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.

The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.

Researchers have outfitted brewer’s yeast with light-harvesting semiconductors to boost chemical productivity.

Using bioinformatics, two teams of scientists identified inhibitory proteins for Cas9’s relative.

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

Under one name the species is used in food fermentation, and under the other it is a drug-resistant cause of yeast infections.

The new technique uses an enzyme found in vertebrate immune systems to attach nucleotides to a growing strand.  

Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.